ADRs (Adverse Drug Reactions) related to ayurvedic medicine used in COVID-19

Authors

  • Manju Kumari MD Scholar, Department of Dravyaguna, National Institute of Ayurveda (Deemed University), Jaipur, Rajasthan, India
  • A Ramamurthy Professor, Department of Dravyaguna, National Institute of Ayurveda (Deemed University), Jaipur, Rajasthan, India
  • Sudipta Rath Associate Professor, Department of Dravyaguna, National Institute of Ayurveda (Deemed University), Jaipur, Rajasthan, India
  • Syed Ziaur Rahman Professor, Department of Pharmacology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

DOI:

https://doi.org/10.3329/bjms.v23i1.70756

Keywords:

Pharmacovigilance; Suspected ADR; Cap. Ayush 64; Sanshamni vati

Abstract

Background: Adverse Drug Reaction (ADR) is a response to a drug which is noxious and unintended, and which occurs at therapeutic doses. Due to a lack of systematic documentation regarding the occurrence of ADR and other issues to the safety of Ayurvedic medicines, concern about the traditional medical system has recently been increased. This is seen by a rise in safety reports and misunderstandings, especially in the recent pandemic.

Objective: To monitor and analyse the suspected ADR to Ayurvedic medicines used in COVID-19.

Materials and Methods: ADR monitoring data was collected through spontaneous and intensive method for a span of 2-year (April 2020 to April 2022) during the peak days of COVID-19 from the IPvCC of the National Institute of Ayurveda, Jaipur, India. The IPvCC Program is governed by NPvCC under the supervision of Ministry of AYUSH, Govt. of India, New Delhi. NPvCC is ultimately responsible to monitor and recommend regulatory interventions on the generated national ADR data.

Result: In a span of two-year, 142 adverse drug events were reported out of which 17 were confirmed as ADR due to suspected Ayurvedic drugs.

Conclusion: Overall review demonstrated that Ayurveda has traditionally been placed a strong emphasis on treatments that aim to heal the underlying illness while preventing the development of new illnesses.

Bangladesh Journal of Medical Science Vol. 23 No. 01 January’24 Page : 237-245

Downloads

Download data is not yet available.
Abstract
148
PDF
204

Downloads

Published

2024-01-01

How to Cite

Kumari, M. ., Ramamurthy, A., Rath, S. ., & Rahman, S. Z. . (2024). ADRs (Adverse Drug Reactions) related to ayurvedic medicine used in COVID-19. Bangladesh Journal of Medical Science, 23(1), 237–245. https://doi.org/10.3329/bjms.v23i1.70756

Issue

Vol. 23 No. 1 (2024)

Section

Original Articles

License

Copyright (c) 2024 Manju Kumari, A Ramamurthy, Sudipta Rath, Syed Ziaur Rahman

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.